Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Reports October 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference
Freeline Reports First Quarter 2022 Financial Results and Business Highlights
Freeline Announces First Patient Dosed in the Phase 1/2 B-LIEVE Dose-Confirmation Trial in Hemophilia B
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels